SOX4 and prostate cancer: Immunohistochemistry studies of 85 prostate cancer cases revealed also complete absence of SOX-4 nuclear expression in 19 (22.4%) of specimens, weak SOX-4 nuclear expression in 61 (71.7%) and high nuclear expression of SOX-4 in 5 patients (5.9%).